Chengdu Kanghua Biological Products Co Ltd Sustainability Reports
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, and sale of biological products and vaccines for human use in China. Its main products include freeze-dried human rabies vaccines and meningococcal polysaccharide vaccines.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG00MZ2NKK6
2 reports from 2023 to 2024